tirzepatide skin sensitivity & Zepbound Rash and Injection-Site Reactions: Causes, Treatment, and Prevention Tirzepatide Injection for Weight Loss

Ozempic's active ingredient is semaglutide, described by Pulse & Remedy as a GLP-1 receptor agonist that mimics the hormone glucagon-like peptide-1 to regulate appetite, insulin secretion, and blood sugar

& Murray, P

All under the guidance of a clinician who determines eligibility. Because of the changing market and increasing demand, Weight Watchers Clinic now offers compounded semaglutide: In October (2024), we introduced compounded semaglutide into its offering, broadening eligible members access to clinical weight management interventions

Given the growing use of these medications, especially for weight loss, further prospective studies and clinical trials are warranted to better define their long-term cancer-related safety profile

Orforglipron (Orfoglip), approved in 2025, is an oral GLP-1 agonist for obesity